Shengkai Zuo
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Immunology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Topics
- Peptidase Inhibition and Analysis (5 papers)Cardiac Fibrosis and Remodeling (5 papers)Signaling Pathways in Disease (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Shengkai Zuo
26 papers receiving 609 citations
Peers
Comparison fields: 5 of 82
- Molecular Biology 279
- Cardiology and Cardiovascular Medicine 124
- Immunology 116
- Pulmonary and Respiratory Medicine 83
- Cancer Research 75
Countries citing papers authored by Shengkai Zuo
This map shows the geographic impact of Shengkai Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengkai Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengkai Zuo more than expected).
Fields of papers citing papers by Shengkai Zuo
This network shows the impact of papers produced by Shengkai Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengkai Zuo. The network helps show where Shengkai Zuo may publish in the future.
Co-authorship network of co-authors of Shengkai Zuo
This figure shows the co-authorship network connecting the top 25 collaborators of Shengkai Zuo. A scholar is included among the top collaborators of Shengkai Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengkai Zuo. Shengkai Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 67 | |
| 8 | 3 | |
| 9 | 19 | |
| 10 | 26 | |
| 11 | 17 | |
| 12 | 24 | |
| 13 | 30 | |
| 14 | 69 | |
| 15 | 42 | |
| 16 | 42 | |
| 17 | 18 | |
| 18 | 39 | |
| 19 | 13 | |
| 20 | 39 |
About Shengkai Zuo
Shengkai Zuo is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Oncology, having authored 30 papers that have together received 613 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Cardiac Fibrosis and Remodeling (5 papers) and Signaling Pathways in Disease (3 papers). The work is most often cited by research in Biochemistry (56 citations), Immunology (116 citations) and Cardiology and Cardiovascular Medicine (124 citations). Shengkai Zuo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Ying Yu, Yujun Shen, Deping Kong, Jiao Liu, Bei Wang, Michael Lazarus, Guizhu Liu, Yuxuan Jin, Yuanyang Wang and Qian Liu. Their work appears in journals such as Circulation, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.